In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC …
DE Wiskirchen, P Koomanachai… - Antimicrobial agents …, 2011 - Am Soc Microbiol
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
[PDF][PDF] In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a …
DE Wiskirchen, P Koomanachai… - ANTIMICROBIAL …, 2011 - researchgate.net
MATERIALS AND METHODS Bacterial strains and susceptibility testing. Five clinical K.
pneumoniae isolates, all modified Hodge test positive and blaKPC-2 or blaKPC-3 positive …
pneumoniae isolates, all modified Hodge test positive and blaKPC-2 or blaKPC-3 positive …
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC …
DE Wiskirchen, P Koomanachai, AM Nicasio… - 2011 - cabidigitallibrary.org
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
[引用][C] In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a …
DE WISKIRCHEN, P KOOMANACHAI… - Antimicrobial …, 2011 - pascal-francis.inist.fr
In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in
Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase …
Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase …
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC …
DE Wiskirchen, P Koomanachai, AM Nicasio… - 2011 - repository.li.mahidol.ac.th
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC …
DE Wiskirchen, P Koomanachai… - Antimicrobial …, 2011 - mahidol.elsevierpure.com
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC …
DE Wiskirchen, P Koomanachai… - Antimicrobial Agents …, 2011 - europepmc.org
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
[HTML][HTML] In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a …
DE Wiskirchen, P Koomanachai… - Antimicrobial Agents …, 2011 - ncbi.nlm.nih.gov
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC …
DE Wiskirchen, P Koomanachai… - Antimicrobial …, 2011 - pubmed.ncbi.nlm.nih.gov
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC …
DE Wiskirchen, P Koomanachai… - Antimicrobial Agents …, 2011 - europepmc.org
Multidrug-resistant Klebsiella pneumoniae strains that produce a serine carbapenemase
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …
(KPC) are emerging worldwide, with few therapeutic options that retain consistent …